The docket

Patent litigations.

6,606 cases tracked. Click any row for full case detail; use the buckets below to slice by patent, plaintiff, or defendant. Manage cases (upload CSV, edit, delete) in Admin.

Demand letter analyzer

You got a patent demand letter. Now what?

Paste the letter — we extract the asserted patents, identify the asserter, characterize their litigation history, flag validity vulnerabilities, and draft a sample response letter your attorney can review. Free, private, ~2-3 minutes.

Analyze a letter →

Patent litigation filed per year

1986: 2 cases'861988: 1 case1990: 1 case'901992: 1 case1993: 1 case'941996: 3 cases1997: 2 cases1998: 3 cases'981999: 3 cases2000: 3 cases2001: 5 cases'022003: 10 cases2004: 4 cases2005: 13 cases2006: 15 cases'062007: 17 cases2008: 20 cases2009: 12 cases2010: 39 cases'102011: 36 cases2012: 68 cases2013: 110 cases2014: 95 cases'142015: 107 cases2016: 103 cases2017: 163 cases2018: 171 cases'182019: 198 cases2020: 226 cases2021: 254 cases2022: 358 cases'222023: 321 cases2024: 548 cases2025: 758 cases7582026: 333 cases'26
6,606 tracked cases by filing year.

Analyze a patent

Drop a US patent number — we’ll verify it on Google Patents and generate the full invalidity dossier.

By industry

All litigations

CasePatentsCourtFiledStatus
Untitled case2:18-cv-08964U.S. District Court for the District of New Jersey——
Celgene Corporation v. Lotus Pharmaceutical Co., Ltd. et al.2:17-cv-06842U.S. District Court for the District of New Jersey—consent judgment
Celgene Corporation v. Dr. Reddy's Laboratories2:21-cv-02111D.N.J.—consolidated
CenterWell Pharmacy, Inc. v. Celgene Corp. et al.1:23-cv-07871U.S. District Court for the Southern District of New York (S.D.N.Y.)—unknown
In re Pomalyst (pomalidomide) Antitrust LitigationU.S. District Court for the Southern District of New York (S.D.N.Y.)—dismissed; leave to amend sought
In re Revlimid and Thalomid (Pomalyst) Purchaser Antitrust Litigation2:19-cv-07532-ES-MAHU.S. District Court, District of New Jersey—consolidated
Celgene Corp. v. Mylan Pharmaceuticals Inc. et al.21-1154U.S. Court of Appeals for the Federal Circuit—affirmed
CenterWell v. Celgene/BMS——antitrust follow-on litigation
Cigna/The Cigna Group v. Celgene/BMSUnited States District Court for the Southern District of New York—antitrust follow-on litigation
Celgene Corporation v. Mylan Pharmaceuticals Inc.21-1154United States Court of Appeals for the Federal Circuit—on appeal
Celgene Corporation v. Teva Pharmaceuticals USA, Inc.2:19-cv-08758United States District Court for the District of New Jersey—settled
Beatbot Technology (USA) Co. Ltd. v. Zodiac Pool Systems LLC3:25-cv-01946N.D. Cal.—pending
In re Revlimid & Thalomid Purchaser Antitrust Litigation2:19-cv-07532D.N.J.—pending/consolidated
Untitled case2:18-cv-10775D.N.J.——
Celgene Corporation v. Hetero Labs Limited2:20-cv-02601D.N.J.—settled
Celgene Corporation v. Hetero Labs Ltd. et al.2:17-cv-03387D.N.J.—settled
Untitled case2:17-cv-03159U.S. District Court for the District of New Jersey—unverified
The Cigna Group v. Celgene Corporation1:25-cv-05237-ERU.S. District Court for the Southern District of New York—on appeal
In re Pomalyst Antitrust LitigationU.S. District Court for the Southern District of New York—on appeal
Celgene Corporation v. Mylan Pharmaceuticals Inc.21-1154U.S. Court of Appeals for the Federal Circuit—affirmed